Primaquine–quinoxaline 1,4‑di‑N‑oxide hybrids with action on the exo‑erythrocytic forms of Plasmodium induce their efect by the production of reactive oxygen species

by Bonilla‑Ramírez, L. (Leonardo), Galiano, S. (Silvia), Quiliano, M. (Miguel), Aldana, I. (Ignacio), Pabon, A. (Adriana)
Published 2022

New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities

by Barea, C. (Carlos), Pabon, A. (Adriana), Castillo, D. (Denis), Zimic, M. (Mirko), Quiliano, M. (Miguel), Galiano, S. (Silvia), Pérez-Silanes, S. (Silvia), Monge, A. (Antonio), Deharo, E. (Eric), Aldana, I. (Ignacio)
Published 2012

Aryl piperazine and pyrrolidine as antimalarial agents. Synthesis and investigation of structure-activity relationships

by Mendoza, A. (Adela), Pérez-Silanes, S. (Silvia), Quiliano, M. (Miguel), Pabon, A. (Adriana), Gonzalez, G. (Germán), Garavito, G. (Giovanny), Zimic, M. (Mirko), Vaisberg, A. (Abrahm), Aldana, I. (Ignacio), Monge, A. (Antonio), Deharo, E. (Eric)
Published 2011

New quinoxaline 1,4-di-N-oxide derivatives: Trypanosomaticidal activities and enzyme docking simulation

by Estevez, Y. (Yannick), Quiliano, M. (Miguel), Burguete, A. (Asunción), Cabanillas, B. (Billy), Zimic, M. (Mirko), Malaga, E. (Edith), Verastegui, M. (Manuela), Pérez-Silanes, S. (Silvia), Aldana, I. (Ignacio), Monge, A. (Antonio), Castillo, D. (Denis), Deharo, E. (Eric)
Published 2014